activity
20162026
most citedTime-dependent mediators in survival analysis: Modelling direct and indirect effects with the additive hazards model

58 citations · 177 across the 41 of their papers we have counts for

collaborators

48 papers

stat.ME2026

Estimand frameworks for causal inference in clinical research and regulatory decision making

Miguel A. Hernán, Mats J. Stensrud, Xabier García-Albéniz +2

Causal inference for clinical and regulatory decision making requires a precise definition of the causal estimand, that is, what we want to estimate. Three frameworks are commonly…

stat.ME2026

Optimal sequential decision-making with initiation regimes

Julien D. Laurendeau, Leora Sarvet, Mats J. Stensrud

Consider an optimal dynamic treatment regime, correctly identified from a large, perfectly executed sequentially randomized experiment. Even when the experimenta…

stat.ME2026

Causal inference with staggered entries and effects that change over calendar time

Lorenzo Gasparollo, Mats J. Stensrud

Studies with staggered entry, in which individuals enroll at different calendar times, are ubiquitous in medicine and related disciplines. Because these studies usually have a fixe…

stat.ME2026

On the choice of using raw or demographically-corrected scores

Ignacio Gonzalez-Perez, Mats Julius Stensrud, Marco Piccininni

Demographic corrections are routinely performed in many disciplines, including psychology. Yet, there are ongoing debates about whether these corrections are appropriate and improv…

stat.ME2026

Causal Inference for All: Marginal Estimands for Outcomes Truncated by Death

Ruixuan Zhao, Mats Stensrud, Linbo Wang

In longitudinal studies, outcomes of interest are often truncated by death, meaning that they are only observed or well-defined conditional on intercurrent events such as survival.…

stat.AP2026

Trust Me, I'm a Doctor?

Zach Shahn, Mats Stensrud

Clinical trials usually target average treatment effects, but treatment decisions are made for individuals. This tension motivates a common criticism of evidence-based medicine: a…

stat.ME2026

Sample splitting for valid statistical inference in target trial emulations

Mats Julius Stensrud

\noindent Target trial emulation has improved comparative effectiveness research by making the causal question, assumptions, and analysis plan explicit. However, target trial proto…

stat.ME2026

On causal inference with marked point process data

Pål Christie Ryalen, Mats Julius Stensrud, Kjetil Røysland

We define dynamic treatment regimes and associated potential outcomes for data described by marked point processes (MPPs). These definitions motivate MPP analogues of the commonly…

stat.ME2026

Effects conditional on post-treatment events generated by independent mechanisms

Marco Piccininni, Mats J. Stensrud

In both observational studies and randomized trials, post-treatment events such as dropout, nonadherence, and truncation by death occur frequently. In some studies, conditioning on…

stat.ME2026

Causal Vaccine Effects on Post-infection Outcomes in the Naturally Infected

Allison Codi, Elizabeth Rogawski McQuade, Razieh Nabi +3

Understanding vaccine effects on post-infection outcomes is critical for evaluating the full value proposition of a vaccine. However, defining appropriate causal effects on such ou…

stat.AP2025

Counterfactual Harm: A Counter-argument

Amit N. Sawant, Mats J. Stensrud

As AI systems are increasingly used to guide decisions, it is essential that they follow ethical principles. A core principle in medicine is non-maleficence, often equated with ``d…

stat.ME2025

A simple and powerful test of vaccine waning

Gellért Perényi, Matias Janvin, Mats J. Stensrud

Determining whether vaccine efficacy wanes is important for individual and public decision making. Yet, quantification of waning is a subtle task. The classical approaches cannot b…

econ.EM2025

Interpretational errors with instrumental variables

Luca Locher, Mats J. Stensrud, Aaron L. Sarvet

Instrumental variables (IV) are often used to identify causal effects in observational settings and experiments subject to non-compliance. Under canonical assumptions, IVs allow us…

stat.AP2025

Add-On Regimes and Their Relevance for Quantifying the Effects of Opioid-Sparing Treatments

Catharina Stoltenberg, Matias Janvin, Mats Julius Stensrud +2

Medical researchers and practitioners want to know if supplementing opioid treatments with other analgesics, such as nonsteroidal anti-inflammatory drugs (NSAIDs), can reduce opioi…

stat.ME2025

Encoding and inference on separable effects for sustained treatments

Ignacio Gonzalez-Perez, Kerollos Nashat Wanis, Aaron Leor Sarvet +1

Sustained treatment strategies are common in many domains, particularly in medicine, where many treatment are delivered repeatedly over time. The effects of adherence to a treatmen…

stat.ME2025

Refining the Notion of No Anticipation in Difference-in-Differences Studies

Marco Piccininni, Eric J. Tchetgen Tchetgen, Mats J. Stensrud

We address an ambiguity in identification strategies using difference-in-differences, which are widely applied in empirical research, particularly in economics. The assumption comm…

stat.ME2025

Target trial emulation without matching: a more efficient approach for evaluating vaccine effectiveness using observational data

Emily Wu, Elizabeth Rogawski McQuade, Mats Stensrud +2

Real-world vaccine effectiveness has increasingly been studied using matching-based approaches, particularly in observational cohort studies following the target trial emulation fr…

stat.ME2024

Nonparametric tests of treatment effect homogeneity for policy-makers

Oliver Dukes, Mats J. Stensrud, Riccardo Brioschi +1

Recent work has focused on nonparametric estimation of conditional treatment effects, but inference has remained relatively unexplored. We propose a class of nonparametric tests fo…

stat.AP2024

Variant Specific Treatment Effects with Applications in Vaccine Studies

Gellert Perenyi, Mats J. Stensrud

Pathogens usually exist in heterogeneous variants, like subtypes and strains. Quantifying treatment effects on the different variants is important for guiding prevention policies a…

stat.ME2024★ 1 cited

Causal inference for N-of-1 trials

Marco Piccininni, Mats J. Stensrud, Zachary Shahn +1

The aim of personalized medicine is to tailor treatment decisions to individuals' characteristics. N-of-1 trials are within-person crossover trials that hold the promise of targeti…

stat.ME2024★ 3 cited

Quantification of vaccine waning as a challenge effect

Matias Janvin, Mats J. Stensrud

Knowing whether vaccine protection wanes over time is important for health policy and drug development. However, quantifying waning effects is difficult. A simple contrast of vacci…

stat.ME2024

Improved bounds and inference on optimal regimes

Julien D. Laurendeau, Aaron L. Sarvet, Mats J. Stensrud

Point identification of causal effects requires strong assumptions that are unreasonable in many practical settings. However, informative bounds on these effects can often be deriv…

stat.ME2024

Optimal regimes with limited resources

Aaron L. Sarvet, Julien D. Laurendeau, Mats J. Stensrud

Policy-makers are often faced with the task of distributing a limited supply of resources. To support decision-making in these settings, statisticians are confronted with two chall…

stat.AP2024

Rejoinder to "Perspectives on `harm' in personalized medicine -- an alternative perspective"

Aaron L. Sarvet, Mats J. Stensrud

In our original article (Sarvet & Stensrud, 2024), we examine twin definitions of "harm" in personalized medicine: one based on predictions of individuals' unmeasurable response ty…